Highlights and Quick Summary
- EPS Growth (diluted) for the quarter ending June 30, 2023 was 8.0% (a -300.0% decrease compared to previous quarter)
- Year-over-year quarterly EPS Growth (diluted) decreased by -89.33%
- Annual EPS Growth (diluted) for 2022 was 3.13% (a Infinity% increase from previous year)
- Annual EPS Growth (diluted) for 2021 was 0.0% (a -100.0% decrease from previous year)
- Annual EPS Growth (diluted) for 2020 was 100.0% (a 300.0% increase from previous year)
Visit stockrow.com/DRRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS Growth (diluted) of DURECT Corporation
Most recent EPS Growth (diluted)of DRRX including historical data for past 10 years.Interactive Chart of EPS Growth (diluted) of DURECT Corporation
DURECT Corporation EPS Growth (diluted) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 8.0% | -4.0% | – | – | – |
| 2022 | -53.33% | 75.0% | -25.0% | 0.0% | 3.13% |
| 2021 | -250.0% | 20.0% | -157.14% | 0.0% | 0.0% |
| 2020 | 200.0% | -400.0% | 275.0% | -25.0% | 100.0% |
| 2019 | 60.0% | 50.0% | 0.0% | 20.0% | 25.0% |
| 2018 | -200.0% | -150.0% | 42.86% | 16.67% | -433.33% |
| 2017 | 183.33% | 166.67% | 0.0% | 0.0% | 88.46% |
| 2016 | -20.0% | -20.0% | -40.0% | -50.0% | -36.84% |
| 2015 | 0.0% | 16.67% | 0.0% | -33.33% | 5.0% |
| 2014 | 0.0% | 0.0% | 0.0% | 40.0% | 4.76% |
| 2013 | 16.67% | -20.0% | 0.0% | -114.29% | -216.67% |
| 2012 | -2900.0% | -733.33% | – | – | 957.14% |
Business Profile of DURECT Corporation
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic